Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution: a Randomized, Outcome-assessor Blinded, Proof-of-concept Study (IMEMPRO)

NCT05919940 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT05919940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05919940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution: a Randomized, Outcome-assessor Blinded, Proof-of-concept Study (IMEMPRO)
Lead sponsor
Technical University of Munich
Phase
Not applicable
Overall status
Recruiting
Start date
June 27, 2023
Completion date
January 31, 2027
Enrollment
40 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

energy malnutrition protein, icu acquired weakness, metabolic disturbance, morphological and microscopic findings, muscle atrophy, quality of life